Pharmacokinetics and dose individualization of ceftriaxone in a hepatically-impaired, critically-ill patient receiving continuous venovenous hemofiltration

被引：1
|
作者：
Meenks, Sjoerd D. [1 ]
Foudraine, Norbert A. [2 ]
Janssen, Paddy K. C. [1 ,3 ]
le Noble, Jos L. M. L. [2 ,4 ]
机构：
[1] VieCuri Med Ctr, Dept Hosp Pharm, Venlo, Netherlands
[2] VieCuri Med Ctr, Dept Intens Care, Venlo, Netherlands
[3] Dept Clin Pharm & Toxicol, Maastricht, Netherlands
[4] Dept Pharmacol & Toxicol, Maastricht, Netherlands
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2018年 / 56卷 / 03期
关键词：
PROTEIN-BINDING; CLEARANCE;
D O I：
10.5414/CP203149
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：148 / 150
页数：3
相关论文
共 50 条
  • [1] Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
    Franquiz, Miguel J.
    Kalaria, Shamir N.
    Armahizer, Michael J.
    Gopalakrishnan, Mathangi
    McCarthy, Paul J.
    Badjatia, Neeraj
    PHARMACOTHERAPY, 2018, 38 (02): : E17 - E21
  • [2] Fluconazole Pharmacokinetics in a Morbidly Obese, Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
    Lopez, Natasha D.
    Phillips, Kristy M.
    PHARMACOTHERAPY, 2014, 34 (09): : A162 - A168
  • [3] Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration
    Chunlu Gao
    Jing Tong
    Kaijiang Yu
    Zhidan Sun
    Ran An
    Zhimin Du
    European Journal of Clinical Pharmacology, 2016, 72 : 823 - 830
  • [4] Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration
    Gao, Chunlu
    Tong, Jing
    Yu, Kaijiang
    Sun, Zhidan
    An, Ran
    Du, Zhimin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (07) : 823 - 830
  • [5] Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
    Oliver, Wesley D.
    Heil, Emily L.
    Gonzales, Jeffrey P.
    Mehrotra, Shailly
    Robinett, Kathryn
    Saleeb, Paul
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1899 - 1901
  • [6] Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration
    Ververs, TFT
    van Dijk, A
    Vinks, SATMM
    Blankestijn, PJ
    Savelkoul, TJF
    Meulenbelt, J
    Boereboom, FTJ
    CRITICAL CARE MEDICINE, 2000, 28 (10) : 3412 - 3416
  • [7] Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients
    Guenter, SG
    Iven, H
    Boos, C
    Bruch, HP
    Muhl, E
    PHARMACOTHERAPY, 2002, 22 (02): : 175 - 183
  • [8] Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
    B Meyer
    G Kornek
    M Nikfardjam
    G Delle Karth
    G Heinz
    G Locker
    W Jaeger
    F Thalhammer
    Critical Care, 8 (Suppl 1):
  • [9] Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltration
    Wieringa, Andre
    ter Horst, Peter G. J.
    Wagenvoort, GertJan H. J.
    Koch, Birgit C. P.
    Haringman, Jasper J.
    ANTIVIRAL THERAPY, 2023, 28 (01)
  • [10] Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration
    Wenzler, Eric
    Bunnell, Kristen L.
    Bleasdale, Susan C.
    Benken, Scott
    Danziger, Larry H.
    Rodvold, Keith A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
12345